Give the gift of LIFE! Support the Population Research Institute!

[pri_banner_wppb]

Topics: ectopic pregnancy

FDA to Review Concerns on the Essure Sterilization Procedure



Reviewing Side Effects of Essure by FDA After receiving thousands of complaints of adverse side-effects, the FDA has decided to conduct a hearing on the safety and effectiveness of Essure. The controversial sterilization implant involves pushing micro coils made of nitinol (a nickel-titanium alloy) and polyethylene terephthalate (PET) fibers into a woman’s fallopian tubes via a hysteroscope and catheter. This scars the fallopian tubes and seals them shut. Originally developed by Conceptus, the Essure system …

Read more.




Reproductive Health Mortality



Population controllers are constantly talking about “reproductive health,” and their burning desire to reduce maternal mortality worldwide. This is the excuse that they use for pushing contraception, legalized abortion, and sterilization on developing countries all over the world. However, this is simply a ploy to make their real purpose more palatable: controlling the world’s “booming” population. Those Who Suffer Babies and children are not the only ones who suffer from this misguided mission. Mothers and …

Read more.




Reproductive Health Mortality



12 November 2007     Vol. 9 / No. 42 REPRODUCTIVE HEALTH MORTALITY Population controllers are constantly talking about "reproductive health," and their burning desire to reduce maternal mortality worldwide.  This is the excuse that they use for pushing contraception, legalized abortion, and sterilization on developing countries all over the world.  However, this is simply a ploy to make their real purpose more palatable: controlling the world’s "booming" population. Babies and children are not the only ones …

Read more.




PRI Commends FDA for denying Over-the-Counter Status to ‘Morning-After Pill’



Commends FDA for denying Over-the-Counter Status to ‘Morning-After Pill’ For Immediate Release: For more information contact: Vince Criste: (540) 622-5240 May 12, 2004 Front Royal, VA – “The FDA is to be commended for denying over-the-counter approval of the so-called ‘morning after pill'” said Steven W. Mosher of the Virginia-based Population Research Institute (PRI). “Making this dangerous drug so easily accessible, especially without age restrictions and excluding parental involvement would have resulted in a public …

Read more.




New Report on FDA Approval of ‘Emergency Contraception’



Press Release Source: Population Reseach New Report on FDA Approval of ‘Emergency Contraception’ WASHINGTON, DC, 31 March 2004 — Population Research Institute has released an in-depth report on so-called “emergency contraception.” The U.S. Food and Drug Administration (FDA) has delayed its decision to act on Women’s Capital Corporation/Barr Laboratories application for over-the-counter (OTC) status for so-called “emergency contraception”(EC), the morning-after pill (MAP). Opposition to OTC/MAP involves concerns that OTC/MAP would increase rates of rape, STDs, …

Read more.




Never miss an update!

Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.